A novel role for junctional adhesion molecule-A in tumor proliferation: Modulation by an anti-JAM-A monoclonal antibody

International Journal of Cancer

Volumn 132, Issue 6, 2013, Pages 1463-1474

  Goetsch, Liliane ^a   Haeuw, Jean François ^a   Beau Larvor, Charlotte ^a   Gonzalez, Alexandra ^a   Zanna, Laurence ^a   Malissard, Martine ^a   Lepecquet, Anne Marie ^a   Robert, Alain ^a   Bailly, Christian ^a   Broussas, Matthieu ^a   Corvaia, Nathalie ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

antitumor antibody; apoptosis; functional approaches; JAM A; junctional adhesion molecule A; proteomics; tumor growth inhibition

Indexed keywords

JUNCTIONAL ADHESION MOLECULE A; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 6F4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CANCER CONTROL; CANCER INHIBITION; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HYBRIDOMA; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY TUMOR; LUNG TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR IMMUNOLOGY; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; KI-67 ANTIGEN; MICE; MICE, INBRED BALB C; NEOPLASMS; RECEPTORS, CELL SURFACE;

EID: 84872907992     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27772     Document Type: Article

References (44)

1. Desgrosellier JS, Cheresh DA,. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010; 10: 9-22.
2. Haeuw JF, Goetsch L, Bailly C, et al. Tetraspanin CD151 as a target for antibody-based cancer immunotherapy. Biochem Soc Trans 2011; 39: 553-8.
3. Nakamoto T, Murayama Y, Oritani K, et al. A novel therapeutic strategy with anti-CD9 antibody in gastric cancers. J Gastroenterol 2009; 44: 889-96.
4. Klosek SK, Nakashiro K, Hara S, et al. CD151 forms a functional complex with c-Met in human salivary gland cancer cells. Biochem Biophys Res Commun 2005; 336: 408-16. (Pubitemid 41267245)
5. Delcourt N, Bockaert J, Marin P,. GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation. Trends Pharmacol Sci 2007; 28: 602-7. (Pubitemid 350166573)
6. Tsukita S, Furuse M, Itoh M,. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2: 285-93. (Pubitemid 33676971)
7. Zhang K, Yao HP, Wang MH,. Activation of RON differentially regulates claudin expression and localization: role of claudin-1 in RON-mediated epithelial cell motility. Carcinogenesis 2008; 29: 552-9. (Pubitemid 351404871)
8. Zoller M,. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 2009; 9: 40-55.
9. Suzuki M, Kato-Nakano M, Kawamoto S, et al. Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers. Cancer Sci 2009; 100: 1623-30.
10. Beck A, Wurch T, Bailly C, et al. Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol 2010; 10: 345-52.
11. Paris L, Tonutti L, Vannini C, et al. Structural organization of the tight junctions. Biochim Biophys Acta 2008; 1778: 646-59. (Pubitemid 351317797)
12. Severson EA, Parkos CA,. Structural determinants of junctional adhesion molecule A (JAM-A) function and mechanisms of intracellular signaling. Curr Opin Cell Biol 2009; 21: 701-7.
13. Babinska A, Kedees MH, Athar H, et al. F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: role in inflammatory thrombosis. Thromb Hemost 2002; 88: 843-50. (Pubitemid 35350778)
14. Babinska A, Kedees MH, Athar H, et al. Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion. Thromb Hemost 2002; 87: 712-21. (Pubitemid 34308431)
15. Ostermann G, Weber KS, Zernecke A, et al. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 2002; 3: 151-8. (Pubitemid 34141445)
16. Wojcikiewicz EP, Koenen RR, Fraemohs L, et al. LFA-1 binding destabilizes the JAM-A homophilic interaction during leukocyte transmigration. Biophys J 2009; 96: 285-93.
17. Naik MU, Naik UP,. Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin alpha v beta 3 specific. J Cell Sci 2006; 119: 490-9.
18. Barton ES, Forrest JC, Connolly JL, et al. Junction adhesion molecule is a receptor for reovirus. Cell 2001; 104: 441-51. (Pubitemid 32206464)
19. Ebnet K, Schulz CU, Meyer zu Brickwedde MK, et al. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem 2000; 275: 27979-88.
20. Bazzoni G, Martinez-Estrada OM, Mueller F, et al. Homophilic interaction of junctional adhesion molecule. J Biol Chem 2000; 275: 30970-6.
21. Ebnet K, Suzuki A, Horikoshi Y, et al. The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM). EMBO J 2001; 20: 3738-48. (Pubitemid 32691785)
22. Naik MU, Naik TU, Suckow AT, et al. Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. Cancer Res 2008; 68: 2194-203. (Pubitemid 351521792)
23. McSherry EA, McGee SF, Jirstrom K, et al. JAM-A expression positively correlates with poor prognosis in breast cancer patients. Int J Cancer 2009; 125: 1343-51.
24. Murakami M, Giampietro C, Giannotta M, et al. Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression. PLoS One 2011; 6: e21242.
25. Wang P, Henning SM, Heber D,. Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS One 2010; 5: e10202.
26. Tomayko MM, Reynolds CP,. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989; 24: 148-54. (Pubitemid 19163397)
27. Broussas M, Dupont J, Gonzalez A, et al. Molecular mechanisms involved in activity of h7C10, a humanized monoclonal antibody, to IGF-1 receptor. Int J Cancer 2009; 124: 2281-93.
28. Liang TW, DeMarco RA, Mrsny RJ, et al. Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation. Am J Physiol Cell Physiol 2000; 279: C1733-C1743.
29. Mandell KJ, McCall IC, Parkos CA,. Involvement of the junctional adhesion molecule-1 (JAM1) homodimer interface in regulation of epithelial barrier function. J Biol Chem 2004; 279: 16254-62. (Pubitemid 38509319)
30. Mandell KJ, Babbin BA, Nusrat A, et al. Junctional adhesion molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and Rap1 activity. J Biol Chem 2005; 280: 11665-74. (Pubitemid 40418481)
31. Mandell KJ, Babbin BA, Nusrat A, et al. Junctional adhesion molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and Rap1 activity. J Biol Chem 2005; 280: 11665-74. (Pubitemid 40418481)
32. McSherry EA, Brennan K, Hudson L, et al. Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase. Breast Cancer Res 2011; 13: R31.
33. Nava P, Capaldo CT, Koch S, et al. JAM-A regulates epithelial proliferation through Akt/beta-catenin signalling. EMBO Rep 2011; 12: 314-20.
34. Rubinfeld B, Upadhyay A, Clark SL, et al. Identification and immunotherapeutic targeting of antigens induced by chemotherapy. Nat Biotechnol 2006; 24: 205-9. (Pubitemid 43221705)
35. Bradfield PF, Nourshargh S, Aurrand-Lions M, et al. JAM family and related proteins in leukocyte migration (Vestweber series). Arterioscler Thromb Vasc Biol 2007; 27: 2104-12. (Pubitemid 350287237)
36. Koshiba H, Hosokawa K, Kubo A, et al. Junctional adhesion molecule A [corrected] expression in human endometrial carcinoma. Int J Gynecol Cancer 2009; 19: 208-13.
37. Aranda V, Haire T, Nolan ME, et al. Par6-APKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat Cell Biol 2006; 8: 1235-45. (Pubitemid 44660588)
38. Atmanene C, Wagner-Rousset E, Malissard M, et al. Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS. Anal Chem 2009; 81: 6364-73.
39. Balda MS, Garrett MD, Matter K,. The ZO-1-Associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol 2003; 160: 423-32. (Pubitemid 36182732)
40. Sourisseau T, Georgiadis A, Tsapara A, et al. Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA. Mol Cell Biol 2006; 26: 2387-98. (Pubitemid 43346937)
41. Morris AP, Tawil A, Berkova Z, et al. Junctional adhesion molecules (JAMs) are differentially expressed in fibroblasts and co-localize with ZO-1 to adherens-like junctions. Cell Commun Adhes 2006; 13: 233-47. (Pubitemid 44256252)
42. Feigin ME, Muthuswamy SK,. Polarity proteins regulate mammalian cell-cell junctions and cancer pathogenesis. Curr Opin Cell Biol 2009; 21: 694-700.
43. Dow LE, Humbert PO,. Polarity regulators and the control of epithelial architecture, cell migration, and tumorigenesis. Int Rev Cytol 2007; 262: 253-302. (Pubitemid 47031311)
44. Koenen RR, Pruessmeyer J, Soehnlein O, et al. Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood 2009; 113: 4799-809.